Prestige Consumer Healthcare
PBH
#3940
Rank
ยฃ2.24 B
Marketcap
ยฃ45.62
Share price
1.27%
Change (1 day)
-31.03%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): ยฃ3.10

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is ยฃ3.05. In 2024 the company made an earnings per share (EPS) of ยฃ3.23 an increase over its 2023 EPS that were of -ยฃ1.21.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ3.10-3.86%
2024ยฃ3.23-367.08%
2023-ยฃ1.21-138.33%
2022ยฃ3.1511.7%
2021ยฃ2.8213.6%
2020ยฃ2.48-651.67%
2019-ยฃ0.45-148.78%
2018ยฃ0.92-83.29%
2017ยฃ5.52437.23%
2016ยฃ1.03-34.13%
2015ยฃ1.5652.94%
2014ยฃ1.02-8.11%
2013ยฃ1.11
2011ยฃ0.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
ยฃ2.70-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ1.29-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-ยฃ22.22-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.83 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.92-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
ยฃ5.52 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
ยฃ5.27 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
ยฃ0.30-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
ยฃ4.81 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.04 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA